Cargando…

Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms

OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic char...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiuchao, Wang, Junjin, Wei, Xi, Zhao, Lihui, Ni, Bo, Li, Zekun, Gao, Chuntao, Gao, Song, Zhao, Tiansuo, Wang, Jian, Ma, Weidong, Hu, Xiao, Hao, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630525/
https://www.ncbi.nlm.nih.gov/pubmed/36350006
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258
_version_ 1784823620991713280
author Wang, Xiuchao
Wang, Junjin
Wei, Xi
Zhao, Lihui
Ni, Bo
Li, Zekun
Gao, Chuntao
Gao, Song
Zhao, Tiansuo
Wang, Jian
Ma, Weidong
Hu, Xiao
Hao, Jihui
author_facet Wang, Xiuchao
Wang, Junjin
Wei, Xi
Zhao, Lihui
Ni, Bo
Li, Zekun
Gao, Chuntao
Gao, Song
Zhao, Tiansuo
Wang, Jian
Ma, Weidong
Hu, Xiao
Hao, Jihui
author_sort Wang, Xiuchao
collection PubMed
description OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic characteristics were collected from patients. Multiple logistic regression was used to identify independent risk factors associated with malignant PCN, which were then included in the nomogram and validated with an external cohort. The Net Reclassification Index (NRI) and Integrated Discrimination Improvement (IDI) were calculated to evaluate the improvement in the predictive power of the new model with respect to that of a combined imaging and tumor marker prediction model. RESULTS: Malignant PCN were found in 83 (40.7%) and 33 (38.7%) of the model and validation cohorts, respectively. Multivariate analysis identified age, tumor location, imaging of tumor boundary, blood type, mean hemoglobin concentration, neutrophil-to-lymphocyte ratio, carbohydrate antigen 19-9, and carcinoembryonic antigen as independent risk factors for malignant PCN. The calibration curve indicated that the predictions based on the nomogram were in excellent agreement with the actual observations. A nomogram score cutoff of 192.5 classified patients as having low vs. high risk of malignant PCN. The model achieved good C-statistics of 0.929 (95% CI 0.890–0.968, P < 0.05) and 0.951 (95% CI 0.903–0.998, P < 0.05) in predicting malignancy in the development and validation cohorts, respectively. NRI = 0.268; IDI = 0.271 (P < 0.001 for improvement). The DCA curve indicated that our model yielded greater clinical benefits than the comparator model. CONCLUSIONS: The nomogram showed excellent performance in predicting malignant PCN and may help surgeons select patients for detailed examination and surgery. The nomogram is freely available at https://wangjunjinnomogram.shinyapps.io/DynNomapp/.
format Online
Article
Text
id pubmed-9630525
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Compuscript
record_format MEDLINE/PubMed
spelling pubmed-96305252022-11-07 Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms Wang, Xiuchao Wang, Junjin Wei, Xi Zhao, Lihui Ni, Bo Li, Zekun Gao, Chuntao Gao, Song Zhao, Tiansuo Wang, Jian Ma, Weidong Hu, Xiao Hao, Jihui Cancer Biol Med Original Article OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic characteristics were collected from patients. Multiple logistic regression was used to identify independent risk factors associated with malignant PCN, which were then included in the nomogram and validated with an external cohort. The Net Reclassification Index (NRI) and Integrated Discrimination Improvement (IDI) were calculated to evaluate the improvement in the predictive power of the new model with respect to that of a combined imaging and tumor marker prediction model. RESULTS: Malignant PCN were found in 83 (40.7%) and 33 (38.7%) of the model and validation cohorts, respectively. Multivariate analysis identified age, tumor location, imaging of tumor boundary, blood type, mean hemoglobin concentration, neutrophil-to-lymphocyte ratio, carbohydrate antigen 19-9, and carcinoembryonic antigen as independent risk factors for malignant PCN. The calibration curve indicated that the predictions based on the nomogram were in excellent agreement with the actual observations. A nomogram score cutoff of 192.5 classified patients as having low vs. high risk of malignant PCN. The model achieved good C-statistics of 0.929 (95% CI 0.890–0.968, P < 0.05) and 0.951 (95% CI 0.903–0.998, P < 0.05) in predicting malignancy in the development and validation cohorts, respectively. NRI = 0.268; IDI = 0.271 (P < 0.001 for improvement). The DCA curve indicated that our model yielded greater clinical benefits than the comparator model. CONCLUSIONS: The nomogram showed excellent performance in predicting malignant PCN and may help surgeons select patients for detailed examination and surgery. The nomogram is freely available at https://wangjunjinnomogram.shinyapps.io/DynNomapp/. Compuscript 2022-10-15 2022-11-01 /pmc/articles/PMC9630525/ /pubmed/36350006 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258 Text en Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Wang, Xiuchao
Wang, Junjin
Wei, Xi
Zhao, Lihui
Ni, Bo
Li, Zekun
Gao, Chuntao
Gao, Song
Zhao, Tiansuo
Wang, Jian
Ma, Weidong
Hu, Xiao
Hao, Jihui
Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title_full Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title_fullStr Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title_full_unstemmed Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title_short Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
title_sort preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630525/
https://www.ncbi.nlm.nih.gov/pubmed/36350006
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258
work_keys_str_mv AT wangxiuchao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT wangjunjin preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT weixi preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT zhaolihui preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT nibo preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT lizekun preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT gaochuntao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT gaosong preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT zhaotiansuo preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT wangjian preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT maweidong preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT huxiao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms
AT haojihui preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms